Lupin Launches First Cetuximab Biosimilar In India Through Enzene Partnership

DCGI Approved Compound In January

 
• By Chloe Kent

Lupin has collaborated with Alkem subsidiary Enzene Biosciences to launch the first ever cetuximab biosimilar in India. 

More from Biosimilars

More from Products